YAP1 expression is associated with survival and immunosuppression in small cell lung cancer

Immunotherapy is considered a major breakthrough in the treatment of small cell lung cancer (SCLC), although its anti-tumor efficacy is limited. With a high degree of malignancy and high heterogeneity, SCLC is difficult to treat in the clinic. A new combination strategy is urgently needed to further...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peixin, Sun, Chenglong, Wang, Hao, Zhao, Wencheng, Wu, Yan, Guo, Haoyue, Zhou, Caicun, He, Yayi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522695/
https://www.ncbi.nlm.nih.gov/pubmed/37752152
http://dx.doi.org/10.1038/s41419-023-06053-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522695/
https://www.ncbi.nlm.nih.gov/pubmed/37752152
http://dx.doi.org/10.1038/s41419-023-06053-y

Ejemplares similares